Back to all studies
🦴
Phase 1
Pain Management
in-person
A Study of LY4213663 in Healthy Participants and Participants With Rheumatoid Arthritis
Sponsored by Eli Lilly and Company
Compensation
$500–$2,500
Duration
3 months
Location
Multi-State
About this study
The purpose of this study is to evaluate how well LY4213663 is tolerated and what side effects may occur in healthy participants and participants with rheumatoid arthritis (RA). The study drug will be administered either subcutaneously (SC) (under the skin) or intravenously (IV) (into a vein in the arm). Blood tests will be performed to investigate how the body processes the study drug and how the study drug affects the body. The study will last approximately 33 weeks excluding screening.
Who can participate
- • Adults aged 18–75
- • All genders welcome
- • Diagnosed with or experiencing healthy
- • Able to attend in-person clinic visits
What's included
- • Compensation up to $2,500
- • All study-related medical care at no cost
- • Lab work, screenings, and physician consultations
- • Study medication or treatment provided
IRB-approved study. Free to apply. Your information is kept confidential.
Ready to Find a Paid Study?
Join over 100,000 people who have been matched with clinical studies. It's free, fast, and could change your life.